FDA fully approves Pfizer vaccine, making it easier for schools and employers to require vaccinations
The Food and Drug Administration has approved Pfizer and BioNTech's Covid-19 vaccine for people 16 and older — making it the first to be fully licensed for use in the United States.
Pfizer CEO Albert Bourla also expressed hope that the full licensure would increase confidence in the shot. More than 204 million doses of the shot have been administered to people in the United States since it received emergency authorization late last year, and the vaccine is in wide use globally. "Full FDA approval of the Pfizer vaccine is another step forward – to convince more people to get vaccinated, to facilitate mandates, and to save more lives," tweeted Tom Frieden, who led the Centers for Disease Control and Prevention during the Obama administration. "Moderna's full approval shouldn't be far behind – just a matter of timing and paperwork."
The U.S. government has purchased 500 million doses of the Pfizer vaccine for use at home, and another 500 million that it plans to donate to countries in need.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA could grant full approval to Pfizer/BioNTech Covid-19 vaccine today, two officials sayCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Consulte Mais informação »
FDA grants full approval to Pfizer/BioNTech Covid-19 vaccine, opening door to more vaccine mandatesThe US Food and Drug Administration on Monday granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. This is the first coronavirus vaccine approved by the FDA, and is expected to open the door to more vaccine mandates.
Consulte Mais informação »
UK orders 35 million more Pfizer/BioNTech COVID vaccinesBritain has agreed to buy 35 million more doses of the Pfizer/BioNTech (22UAy.DE) COVID-19 vaccine, to be delivered from the second half of next year, as part of its preparations for booster shots and any new variants that could emerge.
Consulte Mais informação »
FDA grants full approval to Pfizer COVID-19 vaccineBREAKING: FDA grants full approval of the Pfizer COVID-19 vaccine, becoming the first COVID-19 vaccine to transition from an emergency authorization status to full FDA approval.
Consulte Mais informação »
Pfizer And Moderna Rally After FDA Grants Full Approval To Pfizer's Covid-19 VaccinePfizer climbed 4%, while its German vaccine partner, BioNTech, soared more than 10%.
Consulte Mais informação »
U.S. FDA aims to give full approval to Pfizer vaccine on Monday -NYTWASHINGTON (Reuters) -The U.S. Food and Drug Administration is aiming to give full approval to Pfizer's COVID-19 vaccine on Monday, the New York Times reported https://www.nytimes.com/2021/08/20/us/politics/fda-pfizer-covid-vaccine-full-approval.html on Friday. The approval could boost the vaccination campaign by convincing more unvaccinated Americans that Pfizer's shot is safe and effective and also make local officials more comfortable in implementing vaccine mandates. The U.S. military is expected to require that service members get vaccinated soon after Pfizer's shot is authorized and other major U.S. employers could follow suit.
Consulte Mais informação »